ILARIS

150 Micromol Pdr for Soln for Injection

Novartis Europharm LimitedEU/1/09/564/1-2

Main Information

Trade NameILARIS
Active SubstancesCANAKINUMAB
Strength150 Micromol
Dosage FormPdr for Soln for Injection
Licence HolderNovartis Europharm Limited
Licence NumberEU/1/09/564/1-2

Group Information

ATC CodeL04AC08 Interleukin inhibitors

Status

Authorised/WithdrawnAuthorised
Licence Issued23/10/2009
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back